⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29427166 | 1.00 | — | — | |
| SCHEMBL108973 | 0.80 | — | — | |
| SCHEMBL254224 | 0.80 | — | — | |
| SCHEMBL2329832 | 0.76 | ALDH1A1 (0.32) | — | |
| SCHEMBL29449513 | 0.76 | ALDH1A1 (0.32) | — | |
| Nitrogen SCHEMBL10700884 | 0.75 | ACHE (0.48) | — | |
| SCHEMBL17395287 | 0.73 | ADRA2A (0.36) | — | |
| SCHEMBL21616726 | 0.72 | ALDH1A1 (0.46) | — | |
| SCHEMBL491287 | 0.72 | — | — | |
| SCHEMBL361070 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004697-A | Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material | 同济大学 | 2025-05-16 | — | — | CN | claimed |
| CN-117304009-A | Preparation method of 3-fluoro-4-methyl-8-oxo-5, 6,7, 8-tetrahydronaphthalene | 韶远科技（上海)有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-115197233-A | Preparation method of irinotecan and intermediate thereof | 山东伊立特生物医药技术有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-102070420-A | Method for preparing 2-bromo-6-fluorobenzaldehyde | UNIV CHANGZHOU | 2011-05-25 | — | — | CN | claimed |
| CN-102070397-A | Method for preparing 2-bromo-fluorobenzyl bromide | UNIV CHANGZHOU | 2011-05-25 | — | — | CN | claimed |
| CN-102060670-A | Preparation method of 2-bromine-6-fluorophenyl methanol | UNIV CHANGZHOU | 2011-05-18 | — | — | CN | claimed |
| CN-122070275-A | Heterocyclic compound and application thereof | 成都麻沸散医药科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260035362-A1 | GLP-1R AGONISTS AND USES THEREOF | QILU REGOR THERAPEUTICS INC (CN) | 2026-02-05 | — | — | US | disclosed |
| US-12365670-B2 | GLP-IR agonists and uses thereof | QILU REGOR THERAPEUTICS INC. (CN) | 2025-07-22 | — | — | US | disclosed |
| EP-4540240-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | Monte Rosa Therapeutics AG (CH) | 2025-04-23 | — | — | EP | disclosed |
| US-20250026758-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | CONTINEUM THERAPEUTICS INC (US) | 2025-01-23 | — | — | US | disclosed |
| CN-119112895-A | Muscarinic acetylcholine M1 receptor antagonists | 康蒂内乌姆医疗公司 | 2024-12-13 | — | — | CN | disclosed |
| EP-4474017-A2 | NEW HETEROCYCLIC COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2024-12-11 | — | — | EP | disclosed |
| US-5696130-A | Tricyclic steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-09 | — | — | US | disclosed |
| US-5693646-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5693647-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5688808-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| US-5688810-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0800519-A1 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS, INC. (US) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996019458-A2 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1996-06-27 | — | — | WO | disclosed |